Skip to main content
Clinical Trials/CTRI/2021/11/038306
CTRI/2021/11/038306
Completed
未知

To evaluate opthalmological and dermatological safety of skin care products on repeated use by subject of varied eye conditions and varied skin conditions

SERY COSMETICS LLP0 sites30 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
SERY COSMETICS LLP
Enrollment
30
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 8, 2021
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
SERY COSMETICS LLP

Eligibility Criteria

Inclusion Criteria

  • 1\. Subject is having valid proof of identity and age.
  • 2\. Subject with skin photo type III to V.
  • 3\. Skin is healthy (free of eczema, wounds, inflammatory scar).
  • 4\. Healthy subjects (no infectious and evaluative pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the
  • study, no symptom in the process of an exploratory check\-up)
  • 5\. Female Subjects in the age group of 18 to 55\.
  • 6\. Subjects representing varied skin types (representation of all 4 skin types ââ?¬â?? Oily,
  • Normal, Dry and combination)
  • 7\. Subjects representing varied eye conditions (representation of Normal Condition,
  • 8\. Sensitive Condition, and Contact Lens Users).

Exclusion Criteria

  • 1\. Subject is either pregnant/ planning a pregnancy, or lactating.
  • 2\. Subject having known history or present condition of allergic response to any
  • cosmetic products (face/eye)/ known or suspected intolerance to cosmetic
  • ingredients including fragrance.
  • 3\. Subject having any eye infection or allergy/ extremely sensitive eye condition.
  • 4\. Subject having any form of cutaneous disease which may Influence the study
  • 5\.Previous history of atopy with regards to allergic reactions, irritation or intense
  • discomfort feelings to topical\-use products, cosmetics or medication.
  • 6\. Any history of significant dermatological diseases or conditions or medical
  • conditions.

Outcomes

Primary Outcomes

Not specified

Similar Trials